Executive Director Global Market Access Strategy
Executive Director Global Market Access Strategy
Employer Active
Job Alert
You will be updated with latest job alerts via email
Share
Job Alert
You will be updated with latest job alerts via email
$ 248000 - 310000
1 Vacancy
Job Description
Why Sarepta Why Now
The promise of genetic medicine has arrived and Sarepta is at the forefront. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limbgirdle muscular dystrophies (LGMDs) and we currently have more than 40 programs in various stages of development in gene therapy RNA and gene editing. In 2023 we launched our fourth therapy and the first ever gene therapy to treat Duchenne.
Were looking for people who see unlimited potential in themselves and who are motivated by an unwavering commitment to patients.
What Sarepta Offers
At Sarepta we care deeply about all the people in our community and believe in the importance of supporting them in all aspects of their lives. We aspire to maintain a culture that acknowledges people bring their whole selves to work and we will strive to help everyone in our community integrate their work and personal lives while maintaining productivity. We are committed to offering a range of benefits and worklife resources designed to support people in the following areas:
Physical and Emotional Wellness
Financial Wellness
Support for Caregivers
For a full list of our comprehensive benefits see our website: Importance of the Role
Reporting to the Head of Global Market Access Strategy (GMAX) the Executive Director GMAX drives market access strategy for key Sarepta assets including ELEVIDYS (delandistrogene moxepavovec SRP9001 with influential leadership that represent the goals and priorities of the broader International Business Unit to cross functional teams such as the Global Product Team (GPT) or Customer Org SubTeam (CT).In collaboration with the broader International Business Unit the GMAX team proactively monitors external market access / evidence generation requirements and drives development of market access strategies including development of the global payer value proposition and evidence generation strategies for Sareptas assets in development as well as marketed therapies to optimize access.
The Opportunity to Make a Difference
Serve as a key member and organizer of cross functional teams; contribute to continuous improvement and development of Market Access function through leadership of functional initiatives and organizational change. Effectively communicate within the organization and be the lead GMAX representative at key internal governance and executive meetings for supported programs.
Partner with internal stakeholders (Commercial Brand Leads Medical Directors Medical Managed Care US Market Access Global teams etc. at strategic and tactical levels to generate and disseminate robust evidentiary data in support of a broad set of partners including payers. Assume financial management responsibilities including budget planning and implementation.
Provide strategic leadership and oversight to all GMAX activities supporting value proposition global market prioritization development and communicating throughout the organization regarding market access needs and strategy for supported programs.
Triage incoming requests for evidence / market access support from International Business partners to ensure timely and relevant responses and lead development of internal materials (e.g. Global Value Dossier) to support local market access submissions.
Closely partner with internal crossfunctional teams to enable and drive payercentricity in all market access and HEOR research and activities for supported programs.
Role model and cultivate a culture of teamwork and coordinate with crossfunctional team to ensure that patientrelevant and reimbursementrelevant endpoints are incorporated into clinical stages of product development to facilitate Sarepta development programs.
Represent HEOR / Market Access function with Alliance (CoDevelopment) partners (e.g. sitting on Alliance crossfunctional Global Product Teams market access subteams etc) as appropriate.
Gather insights on evidence generation needs for key global payer / Health Technology Assessment (HTA) stakeholders and communicate results within Sarepta:
Pressure testing value assumptions and evidence requirements (testing TPP key value drivers)
Payer inputs on value story evidence generation plan
Global reference price tracking
Support Life Cycle Teams by informing potential access barriers or implications of development plans
Identify external market access / HEOR (or other) subject matter experts for potential research collaborations.
Represent Sarepta with external organizations (e.g. ISPOR) or consortia as appropriate.
Other related duties as needed.
More about You
MS required Doctorate in health economics epidemiology statistics public health health policy or related field preferred.
12 years of experience in the pharma or healthcare sector preferably in health economics market access or related functions/fields is required with at least 5 years of global HTA experience preferred.
Proven track record of successful collaboration with crossfunctional teams.
Substantial experience in shaping market access HEOR and RWE strategies supporting pipeline products is strongly preferred.
Experience working in rare disease neuromuscular disorders or cell & gene therapies is preferred.
Substantial experience engaging or partnering with external organizations (e.g. universities value assessors regulatory agencies etc. is strongly preferred.
Excellent communication and presentation skills; fluency working with Microsoft Office.
Ability to travel up to 25.
What Now
Were always looking for solutionoriented critical thinkers.
So if youre comfortable with ambiguity and candor relish challenging yourself and place kindness and integrity at the forefront of how you approach your peers and work then we encourage you to apply.
Required Experience:
Exec
Employment Type
Full-Time
